Document Detail


Dietary fructose inhibits intestinal calcium absorption and induces vitamin D insufficiency in CKD.
MedLine Citation:
PMID:  19959720     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Renal disease leads to perturbations in calcium and phosphate homeostasis and vitamin D metabolism. Dietary fructose aggravates chronic kidney disease (CKD), but whether it also worsens CKD-induced derangements in calcium and phosphate homeostasis is unknown. Here, we fed rats diets containing 60% glucose or fructose for 1 mo beginning 6 wk after 5/6 nephrectomy or sham operation. Nephrectomized rats had markedly greater kidney weight, blood urea nitrogen, and serum levels of creatinine, phosphate, and calcium-phosphate product; dietary fructose significantly exacerbated all of these outcomes. Expression and activity of intestinal phosphate transporter, which did not change after nephrectomy or dietary fructose, did not correlate with hyperphosphatemia in 5/6-nephrectomized rats. Intestinal transport of calcium, however, decreased with dietary fructose, probably because of fructose-mediated downregulation of calbindin 9k. Serum calcium levels, however, were unaffected by nephrectomy and diet. Finally, only 5/6-nephrectomized rats that received dietary fructose demonstrated marked reductions in 25-hydroxyvitamin D(3) and 1,25-dihydroxyvitamin D(3) levels, despite upregulation of 1alpha-hydroxylase. In summary, excess dietary fructose inhibits intestinal calcium absorption, induces marked vitamin D insufficiency in CKD, and exacerbates other classical symptoms of the disease. Future studies should evaluate the relevance of monitoring fructose consumption in patients with CKD.
Authors:
Veronique Douard; Abbas Asgerally; Yves Sabbagh; Shozo Sugiura; Sue A Shapses; Donatella Casirola; Ronaldo P Ferraris
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2009-12-03
Journal Detail:
Title:  Journal of the American Society of Nephrology : JASN     Volume:  21     ISSN:  1533-3450     ISO Abbreviation:  J. Am. Soc. Nephrol.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-08     Completed Date:  2010-03-16     Revised Date:  2011-07-22    
Medline Journal Info:
Nlm Unique ID:  9013836     Medline TA:  J Am Soc Nephrol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  261-71     Citation Subset:  IM    
Affiliation:
Department of Pharmacology and Physiology, UMDNJ-New Jersey Medical School, Newark, NJ 07101-1709, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
25-Hydroxyvitamin D3 1-alpha-Hydroxylase / metabolism
Animals
Bone Density
Calcifediol / metabolism
Calcitriol / metabolism
Calcium / metabolism*
Chronic Disease
Dietary Carbohydrates / adverse effects,  pharmacology*
Disease Models, Animal
Fructose / adverse effects,  pharmacology*
Glucose / pharmacology
Intestinal Absorption / drug effects*
Kidney / metabolism,  surgery
Kidney Diseases / complications,  metabolism*
Male
Nephrectomy
Phosphates / metabolism
Rats
Rats, Sprague-Dawley
Vitamin D Deficiency / etiology,  metabolism*
Grant Support
ID/Acronym/Agency:
AG-12161/AG/NIA NIH HHS; DK075617/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Dietary Carbohydrates; 0/Phosphates; 19356-17-3/Calcifediol; 30237-26-4/Fructose; 32222-06-3/Calcitriol; 50-99-7/Glucose; 7440-70-2/Calcium; EC 1.14.-/25-Hydroxyvitamin D3 1-alpha-Hydroxylase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Whole-genome linkage and association scan in primary, nonsyndromic vesicoureteric reflux.
Next Document:  Systemic Arterial Vasodilation, Vasopressin, and Vasopressinase in Pregnancy.